Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
303360
vs
K
KOSPI 200
Over the past 12 months, Protia Inc has underperformed KOSPI 200, delivering a return of -36% compared to KOSPI 200's +50% growth.
Stocks Performance
303360 vs KOSPI 200
Performance Gap
303360 vs KOSPI 200
Performance By Year
303360 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Protia Inc
Glance View
Protia, Inc. engages in the development, manufacturing, and sale of vitro diagnostic medical devices. The company is headquartered in Seoul, Seoul and currently employs 113 full-time employees. The company went IPO on 2018-12-19. The firm mainly produces allergy diagnostic reagents, allergy diagnostic equipment, point-of-care diagnosis products (POCT), among others. In addition, the Company is engaged in provision of protein related analysis services.